ERCC1 and non-small cell lung carcinoma: In addition, many in vitro and clinical studies have linked resistance to platinum compounds to the levels of ERCC1 mRNA and protein in NSCLC where up to ~40% of tumors harbor low to undetectable ERCC1 expression [6,7,8,9].